Integrative Omics Analysis Reveals Functional Variants of Hemoglobin Zeta (HBZ) as an Ancestry-Specific Risk Factor for Triple-Negative Breast Cancer
Han Le, Amos M. SakweiD, Ashton F. OliveriD, Ayo Priscille DoumateyiD, Ky'Era Actkins, Mileati T. Melese, Rokhaya Ndiaye DialloiD, Amadou GayeiD
Abstract
BackgroundTriple-negative breast cancer (TNBC) disproportionately affects women of African ancestry, yet the biological mechanisms underlying this disparity remain poorly understood. While recent genome-wide association studies (GWAS) have identified numerous TNBC risk variants, their functional consequences have not been systematically evaluated in African-ancestry populations. We hypothesized that ancestry-specific regulatory variants drive distinct transcriptomic and proteomic landscapes that contribute to TNBC aggressiveness. MethodsWe extracted 2,849 unique TNBC-associated variants (p-value [≤] 1x10{square}{square}) from the GWAS Catalog. Of these, 206 were excluded due to absence in our whole-genome sequencing (WGS) dataset or low minor allele frequency ( View larger version (69K): org.highwire.dtl.DTLVardef@ba0dd4org.highwire.dtl.DTLVardef@e1ddc5org.highwire.dtl.DTLVardef@a6e962org.highwire.dtl.DTLVardef@2438db_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Differential expression between African-ancestry and White patients diagnosed with Triple-Negative Breast Cancer: EGFR, Myc, Bcl2 and β-Catenin as ancestry-associated markers
A. T. Matias, A. Jacinta-Fernandes, … P. H. Brito·bioRxiv·Nov 13, 2020
- ZHX2 Promotes HIF1α Oncogenic Signaling in Triple-Negative Breast Cancer
- Whole-genome analysis of Nigerian patients with breast cancer reveals ethnic-driven somatic evolution and distinct genomic subtypes
Naser Ansari‐Pour, Yonglan Zheng, … Olufunmilayo Ibironke Olopade·Nature CommunicationsPeer-reviewed·Nov 26, 2021
- Frequent Whole-Genome Duplication Events Drive the Genomic Evolution of Triple-Negative Breast Cancer During Neoadjuvant Chemotherapy
Devin P Bendixsen, Fiona Semple, … Olga Oikonomidou·bioRxiv·Nov 17, 2025
- Rare non-synonymous germline mutations systematically define the risk of triple negative breast cancer
- Assessing germline mutational profile and its clinicopathological associations in Triple Negative Breast Cancer
Jisha John, Ashwini C. Bapat, … Chaitanyanand B. Koppiker·Cancer GeneticsPeer-reviewed·Jun 18, 2025